Glofitamab With Pirtobrutinib for Relapsed or Refractory Mantle Cell Lymphoma
Clinical trial NCT06252675 · RECRUITING
Trial details
- NCT number
- NCT06252675
- Sponsor
- University of California, San Francisco
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-06-11
- Primary completion
- 2028-07-31
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.